1. Home
  2. STC vs IMCR Comparison

STC vs IMCR Comparison

Compare STC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STC
  • IMCR
  • Stock Information
  • Founded
  • STC 1893
  • IMCR 2008
  • Country
  • STC United States
  • IMCR United Kingdom
  • Employees
  • STC N/A
  • IMCR N/A
  • Industry
  • STC Specialty Insurers
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STC Finance
  • IMCR Health Care
  • Exchange
  • STC Nasdaq
  • IMCR Nasdaq
  • Market Cap
  • STC 2.0B
  • IMCR 1.8B
  • IPO Year
  • STC N/A
  • IMCR 2021
  • Fundamental
  • Price
  • STC $72.89
  • IMCR $32.20
  • Analyst Decision
  • STC Buy
  • IMCR Buy
  • Analyst Count
  • STC 2
  • IMCR 9
  • Target Price
  • STC $77.50
  • IMCR $57.00
  • AVG Volume (30 Days)
  • STC 140.4K
  • IMCR 304.8K
  • Earning Date
  • STC 10-22-2025
  • IMCR 08-07-2025
  • Dividend Yield
  • STC 2.75%
  • IMCR N/A
  • EPS Growth
  • STC 99.80
  • IMCR N/A
  • EPS
  • STC 3.11
  • IMCR N/A
  • Revenue
  • STC $2,668,739,000.00
  • IMCR $356,145,000.00
  • Revenue This Year
  • STC $13.62
  • IMCR $31.83
  • Revenue Next Year
  • STC $12.41
  • IMCR $8.50
  • P/E Ratio
  • STC $23.39
  • IMCR N/A
  • Revenue Growth
  • STC 13.92
  • IMCR 26.78
  • 52 Week Low
  • STC $56.39
  • IMCR $23.15
  • 52 Week High
  • STC $78.44
  • IMCR $39.33
  • Technical
  • Relative Strength Index (RSI)
  • STC 66.42
  • IMCR 42.91
  • Support Level
  • STC $71.96
  • IMCR $31.98
  • Resistance Level
  • STC $73.80
  • IMCR $33.08
  • Average True Range (ATR)
  • STC 1.60
  • IMCR 1.07
  • MACD
  • STC 0.03
  • IMCR 0.04
  • Stochastic Oscillator
  • STC 81.23
  • IMCR 47.20

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: